Mainz Biomed B.V.
NASDAQ:MYNZ
0.3048 (USD) • At close September 13, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Revenue
| 0.895 | 0.53 | 0.577 | 0.494 | 0.281 |
| Cost of Revenue
| 0.386 | 0.348 | 0.4 | 0.37 | 0.343 |
| Gross Profit
| 0.51 | 0.182 | 0.178 | 0.123 | -0.061 |
| Gross Profit Ratio
| 0.569 | 0.344 | 0.308 | 0.249 | -0.218 |
| Reseach & Development Expenses
| 9.59 | 3.66 | 0.467 | 0.312 | 0.25 |
| General & Administrative Expenses
| 13.418 | 17.832 | 8.454 | 0.348 | 0.389 |
| Selling & Marketing Expenses
| 3.803 | 4.979 | 0.958 | 0.11 | 0.181 |
| SG&A
| 17.222 | 22.81 | 9.411 | 0.458 | 0.57 |
| Other Expenses
| 1.11 | -0.114 | -0.321 | -0.291 | -0.13 |
| Operating Expenses
| 27.154 | 26.357 | 9.557 | 0.479 | 0.69 |
| Operating Income
| -26.645 | -26.175 | -9.379 | -0.326 | -0.922 |
| Operating Income Ratio
| -29.755 | -49.398 | -16.245 | -0.66 | -3.276 |
| Total Other Income Expenses Net
| 1.159 | -0.213 | -2.316 | -0.261 | -0.035 |
| Income Before Tax
| -26.296 | -26.387 | -11.695 | -0.587 | -0.957 |
| Income Before Tax Ratio
| -29.365 | -49.799 | -20.257 | -1.189 | -3.401 |
| Income Tax Expense
| 1.919 | 0.065 | 0.377 | 0.299 | 0.218 |
| Net Income
| -26.296 | -26.453 | -12.072 | -0.886 | -1.175 |
| Net Income Ratio
| -29.365 | -49.922 | -20.91 | -1.795 | -4.175 |
| EPS
| -1.62 | -1.87 | -1.67 | -0.16 | -0.1 |
| EPS Diluted
| -1.62 | -1.87 | -1.67 | -0.16 | -0.1 |
| EBITDA
| -24.668 | -25.653 | -9.266 | -0.265 | -0.683 |
| EBITDA Ratio
| -27.548 | -48.413 | -16.05 | -0.538 | -2.426 |